Align Technology ALGN

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$1.42 (+0.90%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Align Technology (ALGN) Business Model and Operations Summary
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Key Insights

Align Technology (ALGN) Core Market Data and Business Metrics
  • Latest Closing Price

    $163.98
  • Market Cap

    $12.07 Billion
  • Price-Earnings Ratio

    27.98
  • Total Outstanding Shares

    73.21 Million Shares
  • Total Employees

    20,945
  • Dividend

    No dividend
  • IPO Date

    January 26, 2001
  • SIC Description

    Orthopedic, Prosthetic & Surgical Appliances & Supplies
  • Primary Exchange

    NASDAQ
  • Headquarters

    410 North Scottsdale Road, Suite 1300, Tempe, AZ, 85288

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Short Interest

Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
Avg Daily VolumeDays to CoverSettlement DateShort Interest
1,530,682 Shares2.493/14/20253,810,848 Shares
1,019,630 Shares3.72/28/20253,776,932 Shares
1,103,663 Shares2.612/14/20252,882,667 Shares
655,866 Shares3.441/31/20252,259,429 Shares
592,642 Shares3.951/15/20252,341,749 Shares
718,808 Shares3.7712/31/20242,707,249 Shares

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow$-196.37 Million
Net Cash Flow From Financing Activities$-502.98 Million
Net Cash Flow From Financing Activities, Continuing$-502.98 Million
Net Cash Flow From Investing Activities$-214.32 Million
Net Cash Flow From Investing Activities, Continuing$-214.32 Million
Net Cash Flow From Operating Activities, Continuing$499.05 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Revenues$3.96 Billion
Diluted Average Shares$149.79 Million
Net Income/Loss Attributable To Parent$441.57 Million
Benefits Costs and Expenses$3.32 Billion
Operating Expenses$2.14 Billion
Net Income/Loss Attributable To Noncontrolling Interest$0

Comprehensive Income

October 1, 2023 to September 30, 2024
MetricValue
Comprehensive Income/Loss$475.44 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Other Comprehensive Income/Loss Attributable To Parent$33.87 Million
Comprehensive Income/Loss Attributable To Parent$475.44 Million
Other Comprehensive Income/Loss$475.44 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Equity Attributable To Parent$3.94 Billion
Current Liabilities$2.06 Billion
Equity$3.94 Billion
Liabilities And Equity$6.37 Billion
Wages$241.64 Million
Liabilities$2.42 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about ALGN from trusted financial sources

    Related Companies

    Publicly traded companies similar to Align Technology (ALGN)